West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST)

Market Closed
30 Apr, 20:00
NYSE NYSE
$
211. 16
-2.3
-1.08%
After Hours
$
211. 16
0 0%
28.24B Market Cap
49.01 P/E Ratio
0.8% Div Yield
46,367 Volume
7.62 Eps
$ 213.46
Previous Close
Day Range
207.9 212.47
Year Range
187.43 372.79

Summary

WST closed today lower at $211.16, a decrease of 1.08% from yesterday's close, completing a monthly decrease of -5.96% or $13.38. Over the past 12 months, WST stock lost -35.95%.
WST pays dividends to its shareholders, with the most recent payment made on Feb 11, 2025. The next announced payment will be in In 1 week on May 07, 2025 for a total of $0.21.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.15%, based on the last three reports.
West Pharmaceutical Services Inc has completed 1 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track WST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

WST Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - WST

Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - WST

NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Accessnewswire | 1 day ago
An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses

An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses

NEW YORK, NY / ACCESS Newswire / April 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Accessnewswire | 5 days ago
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript

West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President and Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Larry Solow - CJS Securities Justin Bowers - Deutsche Bank Michael Ryskin - Bank of America David Windley - Jefferies Daniel Markowitz - Evercore ISI Thomas DeBourcy - Nephron Research Doug Schenkel - Wolfe Research Matt Etoch - Stephens Patrick Donnelly - Citi Matthew Larew - William Blair Kyle Crews - UBS Operator Good day, and thank you for standing by. Welcome to the West Pharmaceutical Services First Quarter 2025 Earnings Conference Call.

Seekingalpha | 6 days ago

West Pharmaceutical Services Inc Dividends

West Pharmaceutical Services Inc logo
WST Today
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc logo
WST 2 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc logo
WST 5 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc logo
WST 8 months ago
Paid
Quarterly
$0.2 Per Share
West Pharmaceutical Services Inc logo
WST 23 Apr 2024
Paid
Quarterly
$0.2 Per Share

West Pharmaceutical Services Inc Earnings

23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS
25 Apr 2024 Date
1.26
Cons. EPS
1.56
EPS
West Pharmaceutical Services Inc logo
WST Today
Announced
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc logo
WST 2 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc logo
WST 5 months ago
Paid
Quarterly
$0.21 Per Share
West Pharmaceutical Services Inc logo
WST 8 months ago
Paid
Quarterly
$0.2 Per Share
West Pharmaceutical Services Inc logo
WST 23 Apr 2024
Paid
Quarterly
$0.2 Per Share
23 Apr 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
1.71
Cons. EPS
1.82
EPS
24 Oct 2024 Date
1.5
Cons. EPS
1.85
EPS
25 Jul 2024 Date
1.74
Cons. EPS
1.52
EPS
25 Apr 2024 Date
1.26
Cons. EPS
1.56
EPS

West Pharmaceutical Services Inc (WST) FAQ

What is the stock price today?

The current price is $211.16.

On which exchange is it traded?

West Pharmaceutical Services Inc is listed on NYSE.

What is its stock symbol?

The ticker symbol is WST.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 28.24B.

Has West Pharmaceutical Services Inc ever had a stock split?

West Pharmaceutical Services Inc had 1 splits and the recent split was on Sep 27, 2013.

West Pharmaceutical Services Inc Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. Eric M. Green CEO
NYSE Exchange
US9553061055 ISIN
US Country
10,600 Employees
30 Apr 2025 Last Dividend
27 Sep 2013 Last Split
13 Jan 1978 IPO Date
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Contact Information

Address: 530 Herman O. West Drive, Exton, PA, United States, 19341-1147
Phone: 610 594 2900